therapeutic 1,175 words KG: GSK3 2026-03-23
kind:therapeuticsection:therapeuticsstate:published
Contents

GSK3 Inhibitor Therapy

💊 Therapeutic Info
NameGSK3
SummaryPage for GSK3 Inhibitor Therapy
Key Genes/ProteinsAKT, MAPK, MTOR, ERK, CDK5
Related DiseasesALZHEIMER'S DISEASE, neurodegeneration
Related PathwaysWnt signaling, Pi3K/Akt Pathway, PI3K/AKT, MAPK signaling, oxidative stress response

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.59
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.69

Related Analyses (24)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · completed
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived

Related Experiments (7)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
P2RY12-MTOR pathway interaction in VSMCs
exploratory · proposed · Score: 0.85
iPSC-NPC transplantation in ICH animal model
validation · proposed · Score: 0.85
Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40

See Also (13)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: activates
Alzheimer Indonesia
institution · KG edge: activates
AMPK (AMP-Activated Protein Kinase)
entity · KG edge: activates
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 4 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 4 hypotheses

Knowledge Graph (12 edges)

GSK3 activates PI3K/AKT SIGNALING
GSK3 activates RAPAMYCIN
GSK3 activates CHAPERONE-MEDIATED AUTOPHAGY
GSK3 regulates AMYLOID-β
GSK3 therapeutic_target NEUROINFLAMMATION
GSK3 associated_with TAU
GSK3 therapeutic_target PARKINSON'S DISEASE
GSK3 contributes_to HUNTINGTON
GSK3 contributes_to HUNTINGTIN
GSK3 therapeutic_target AMYLOID

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)